Patrick Finn
2020
In 2020, Patrick Finn earned a total compensation of $2.9M as Chief Commercial Officer at Twist Bioscience Corp, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,120 |
|---|---|
| Option Awards | $1,407,728 |
| Salary | $417,917 |
| Stock Awards | $774,968 |
| Other | $50,646 |
| Total | $2,876,379 |
Finn received $1.4M in option awards, accounting for 49% of the total pay in 2020.
Finn also received $225.1K in non-equity incentive plan, $417.9K in salary, $775K in stock awards and $50.6K in other compensation.
Rankings
In 2020, Patrick Finn's compensation ranked 4,026th out of 13,090 executives tracked by ExecPay. In other words, Finn earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,026 out of 13,090 | 69th |
Division Manufacturing | 1,623 out of 5,621 | 71st |
Major group Chemicals And Allied Products | 621 out of 2,254 | 72nd |
Industry group Drugs | 534 out of 1,954 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 122 out of 411 | 70th |
Source: SEC filing on January 7, 2021.
Finn's colleagues
We found four more compensation records of executives who worked with Patrick Finn at Twist Bioscience Corp in 2020.
2020
Emily Leproust
Twist Bioscience Corp
Chief Executive Officer
2020
Patrick Weiss
Twist Bioscience Corp
Chief Operating Officer
2020
James Thorburn
Twist Bioscience Corp
Chief Financial Officer
2020
William Banyai
Twist Bioscience Corp